Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison of Duloxetine Hydrochloride, Venlafaxine Extended Release, and Placebo in the Treatment of Generalized Anxiety Disorder.

NCT00122850 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00122850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00122850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison of Duloxetine Hydrochloride, Venlafaxine Extended Release, and Placebo in the Treatment of Generalized Anxiety Disorder.
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2004
Completion date
November 30, 2005
Enrollment
480
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders